Fractionated-Dose Radioimmunotherapy In Non-Hodgkin'S Lymphoma (Nhl) Using Dota-Conjugated, Y-90-Radiolabeled, Humanized Anti-Cd22 Monoclonal Antibody (Epratuzumab). Interim Results.
BLOOD(2003)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
BLOOD(2003)